J Infect Dev Ctries . The biology of SARS-CoV-2 and epidemiological analysis of COVID-19 pandemic in Nigeria

[tetano]

J Infect Dev Ctries


. 2022 Feb 28;16(2):252-257.
doi: 10.3855/jidc.14467.
The biology of SARS-CoV-2 and epidemiological analysis of COVID-19 pandemic in Nigeria


Kingsley Andrew Egbe ¹ , Nathaniel Isaiah Lerum ² , Unah Victor Unah ² , Anthony Chibuogwu Ike ² , Chuks Kenneth Odoh ² , Friday Andrew Egbe ³ , Edith Silas Ekwom ⁴



Affiliations

• PMID: 35298418
• DOI: 10.3855/jidc.14467

Abstract

The pandemic triggered by SARS-CoV-2 continuous to pose a global health threat, with cases of new infections and deaths still occurring despite increasing vaccination efforts. As in other regions of the world, the pandemic has led to unprecedented stretch of health and economic systems in countries in Africa. Nigeria, the most populous African country, has not been spared as the number of new infections continues to teeter amid a high level of vaccination hesitancy. Here, we provided a brief look at the background and biology of the virus. We also highlighted the epidemiology of the virus in Nigeria, as well as the challenges and opportunities it presents. Our review will add to the knowledge of SARS-CoV-2 and the situation of the pandemic in Nigeria, and provide a better response to the pandemic and future pandemics.

Keywords: COVID-19; Coronavirus; Nigeria; Pandemic; epidemiology; pathogenesis.